Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Cevidoplenib dimesylate | 2043659-93-2 | 99.0% | 665.74 g·mol-1 | C27H35N7O9S2 | 5 MG
Supplier: Medchemexpress LLC HY109082A5MG
Cevidoplenib dimesylate is an orally active small-molecule inhibitor of spleen tyrosine kinase (Syk) supplied for research use. It is intended for in vitro and in vivo studies of Syk-mediated signaling, inflammation, and immune modulation, and is available in solid and solution formats to accommodate different experimental workflows.
- High purity suitable for preclinical research.
- Orally bioavailable Syk inhibitor with activity in cellular assays.
- Available as solid vials in multiple sizes and as a DMSO solution.
- Supplied as the dimesylate salt for consistent formulation and handling.
- Compatible with common laboratory solvents, including DMSO, for stock preparation.
- Applicable to pharmacology, immunology, and disease model studies.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?